Buchan AM - Search Results

1

Importance of preclinical research in the development of neuroprotective strategies for ischemic stroke.

Neuhaus AA, Rabie T, Sutherland BA, Papadakis M, Hadley G, Cai R, Buchan AM. Neuhaus AA, et al. Among authors: buchan am. JAMA Neurol. 2014 May;71(5):634-9. doi: 10.1001/jamaneurol.2013.6299. JAMA Neurol. 2014. PMID: 24590416 Review.

2

Prior deafferentation confers long term protection to CA1 against transient forebrain ischemia and sustains GluR2 expression.

Kaur J, Zhao Z, Geransar RM, Papadakis M, Buchan AM. Kaur J, et al. Among authors: buchan am. Brain Res. 2006 Feb 23;1075(1):201-12. doi: 10.1016/j.brainres.2005.12.123. Epub 2006 Feb 9. Brain Res. 2006. PMID: 16480690

3

NXY-059: brain or vessel protection.

Fisher M, Lees K, Papadakis M, Buchan AM. Fisher M, et al. Among authors: buchan am. Stroke. 2006 Aug;37(8):2189-90. doi: 10.1161/01.STR.0000230598.31774.7a. Epub 2006 Jun 29. Stroke. 2006. PMID: 16809574 No abstract available.

4

Improved regional cerebral blood flow is important for the protection seen in a mouse model of late phase ischemic preconditioning.

Hoyte LC, Papadakis M, Barber PA, Buchan AM. Hoyte LC, et al. Among authors: buchan am. Brain Res. 2006 Nov 22;1121(1):231-7. doi: 10.1016/j.brainres.2006.08.107. Epub 2006 Sep 29. Brain Res. 2006. PMID: 17010948

5

Translational vehicles for neuroprotection.

Papadakis M, Buchan AM. Papadakis M, et al. Among authors: buchan am. Biochem Soc Trans. 2006 Dec;34(Pt 6):1318-22. doi: 10.1042/BST0341318. Biochem Soc Trans. 2006. PMID: 17073811 Review.

6

Therapeutic hypothermia in experimental models of focal and global cerebral ischemia and intracerebral hemorrhage.

Nagel S, Papadakis M, Hoyte L, Buchan AM. Nagel S, et al. Among authors: buchan am. Expert Rev Neurother. 2008 Aug;8(8):1255-68. doi: 10.1586/14737175.8.8.1255. Expert Rev Neurother. 2008. PMID: 18671669 Review.

7

Approaches to neuroprotective and reperfusion injury therapy.

Papadakis M, Buchan A. Papadakis M, et al. Handb Clin Neurol. 2009;94:1205-23. doi: 10.1016/S0072-9752(08)94059-8. Handb Clin Neurol. 2009. PMID: 18793896 No abstract available.

8

Ischemic stroke in the elderly: an overview of evidence.

Chen RL, Balami JS, Esiri MM, Chen LK, Buchan AM. Chen RL, et al. Among authors: buchan am. Nat Rev Neurol. 2010 May;6(5):256-65. doi: 10.1038/nrneurol.2010.36. Epub 2010 Apr 6. Nat Rev Neurol. 2010. PMID: 20368741 Review.

9

Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats.

Nagel S, Papadakis M, Chen R, Hoyte LC, Brooks KJ, Gallichan D, Sibson NR, Pugh C, Buchan AM. Nagel S, et al. Among authors: buchan am. J Cereb Blood Flow Metab. 2011 Jan;31(1):132-43. doi: 10.1038/jcbfm.2010.60. Epub 2010 Apr 21. J Cereb Blood Flow Metab. 2011. PMID: 20407463 Free PMC article.

10

The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity.

Harston GW, Sutherland BA, Kennedy J, Buchan AM. Harston GW, et al. Among authors: buchan am. J Cereb Blood Flow Metab. 2010 Nov;30(11):1804-16. doi: 10.1038/jcbfm.2010.149. Epub 2010 Aug 25. J Cereb Blood Flow Metab. 2010. PMID: 20736961 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters